Top

BMC Psychiatry

Published in:

Open Access 01-12-2018 | Research article

The effect of financial incentives on patients’ motivation for treatment: results of “Money for Medication,” a randomised controlled trial

Authors: Ernst L. Noordraven, André I. Wierdsma, Peter Blanken, Anthony F. T. Bloemendaal, Cornelis L. Mulder

Published in: BMC Psychiatry | Issue 1/2018

Abstract

Background

Offering financial incentives is an effective intervention for improving adherence in patients taking antipsychotic depot medication. We assessed whether patients’ motivation for treatment might be reduced after receiving financial rewards.

Methods

This study was part of Money for Medication, a multicentre, open-label, randomised controlled trial, which demonstrated the positive effects of financial incentives on antipsychotic depot compliance. Three mental healthcare institutions in Dutch secondary psychiatric care services participated. Eligible patients were aged 18–65 years, had been diagnosed with schizophrenia or another psychotic disorder, had been prescribed antipsychotic depot medication or had an indication to start using depot medication, and were participating in outpatient treatment. For 12 months, patients were randomly assigned either to treatment as usual (control group) or to treatment as usual plus a financial reward for each depot of medication received (€30 per month if fully compliant; intervention group). They were followed up for 6 months, during which time no monetary rewards were offered for taking antipsychotic medication. To assess treatment motivation after 0, 12 and 18 months, interviews were conducted using a supplement to the Health of the Nation Outcome Scales (HoNOS) and the Treatment Entry Questionnaire (TEQ).

Results

Patients were randomly assigned to the intervention (n = 84) or the control group (n = 85). After 12 months, HoNOS motivation scores were available for 131 patients (78%). Ninety-one percent of the patients had no or mild motivational problems for overall treatment; over time, there were no significant differences between the intervention and control groups. TEQ data was available for a subgroup of patients (n = 61), and showed no significant differences over time between the intervention and control groups for external motivation (β = 0.37 95% CI: -2.49 – 3.23, p = 0.799); introjected motivation (β = − 2.39 95% CI: -6.22 – 1.44, p = 0.222); and identified motivation (β = − 0.91 95% CI: -4.42 – 2.61, p = 0.613). After the 6-month follow-up period, results for the HoNOS and TEQ scores remained comparable.

Conclusions

Offering financial incentives for taking antipsychotic depot medication does not reduce patients’ motivation for treatment.

Trial registration

Netherlands Trial registration, number NTR2350.

Novick D, Haro JM, Suarez D, Perez V, Dittmann RW, Haddad PM. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Res [Internet]. Elsevier Ireland Ltd; 2010 Apr 30 [cited 7 Aug 2013];176(2–3):109–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20185182.

Valenstein M, Ganoczy D, McCarthy JF, Myra Kim H, Lee TA, Blow FC. Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review. J Clin Psychiatry [Internet]. 2006;67(10):1542–50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17107245.CrossRef

Hawton K, Sutton L, Haw C, Sinclair J, Deeks JJ. Schizophrenia and suicide: systematic review of risk factors. Br J Psychiatry. 2005;187:9–20.CrossRefPubMed

Llorca P-M. Partial compliance in schizophrenia and the impact on patient outcomes. Psychiatry Res [Internet]. Elsevier Ireland Ltd; 2008 Nov 30 [cited 23 Aug 2013];161(2):235–47. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18849080.

Fazel S, Zetterqvist J, Larsson H, Langstrom N, Lichtenstein P. Antipsychotics, mood stabilisers, and risk of violent crime. Lancet. 2014;384:1206–14.CrossRefPubMedPubMedCentral

Noordraven EL, Wierdsma AI, Blanken P, Bloemendaal AFT, Staring ABP, Mulder CL. Financial incentives for improving adherence to maintenance treatment in patients with psychotic disorders (Money for Medication): a multicentre, open-label, randomised controlled trial. The Lancet Psychiatry [Internet]. 2017;4(3):199–207. Available from: http://linkinghub.elsevier.com/retrieve/pii/S2215036617300457.CrossRef

Priebe S, Yeeles K, Bremner S, Lauber C, Eldridge S, Ashby D, et al. Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics : cluster randomised controlled trial. BMJ [Internet]. 2013;345(347):f5847. https://doi.org/10.1136/bmj.f5847.CrossRef

Deci EL, Ryan RM, Koestner R. A meta-analytic review of experiments examining the effects of extrinsic rewards on intrinsic motivation. Psychol Bull. 1999;125(6):627–68.CrossRefPubMed

Deci EL, Ryan RM. The ‘ what ’ and ‘ why ’ of goal Pursuits : human needs and the self- determination of behavior the ‘ what ’ and ‘ why ’ of goal Pursuits : human needs and the self-determination of behavior. Psychol Inq. 2000;11(4):227–68.CrossRef

10.

Moller AC, Buscemi J, McFadden HG, Hedeker D, Spring B. Financial motivation undermines potential enjoyment in an intensive diet and activity intervention. J Behav Med. 2013;37(5):819–27.CrossRefPubMedPubMedCentral

11.

Deci EL, Ryan RM. Intrinsic motivation and self-determination in human behavior. New York: Plenum; 1985.CrossRef

12.

Wild TC, Cunningham J a, Ryan RM. Social pressure, coercion, and client engagement at treatment entry: A self-determination theory perspective. Addict Behav [Internet]. 2006 Oct [cited 23 Aug 2013];31(10):1858–72. Available from: https://www.sciencedirect.com/science/article/abs/pii/S030646030600013X.

13.

Davis R, Campbell R, Hildon Z, Hobbs L, Michie S. Theories of behaviour and behaviour change across the social and behavioural sciences: a scoping review. Health Psychol Rev [Internet]. Taylor & Francis. 2015;9(3):323–44. https://doi.org/10.1080/17437199.2014.941722.CrossRef

14.

Noordraven EL, Wierdsma AI, Blanken P, Bloemendaal AFT, Mulder CL. Depot-medication compliance for patients with psychotic disorders : the importance of illness insight and treatment motivation. Neuropsychiatr Dis Treat. 2016;12:269–74.CrossRefPubMedPubMedCentral

15.

Bebbington P, Brugha T, Hill T, Marsden L, Window S. Health of the nation outcome scales (HoNOS). Br J Psychiatry [Internet]. 1999;174:389–94. Available from: https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/validation-of-the-health-ofthe-nation-outcome-scales/2AC20D9FBDC00D4CB3D6EE0C29BC516B.CrossRef

16.

Mulder CL, Staring ABP, Loos J, Buwalda VJA, Kuijpers S, Systema S, et al. De health of the nation outcome scales ( honos ) als instrument voor ‘ routine outcome assessment. Tijdschr Psychiatr. 2004;6(5):273–84.

17.

Ryan RM, Plant RW, O’Malley SS. Initial motivations for alcohol treatment relations with patient characteristics. Treatment Involvement and Dropout Addict Behav. 1995;20(3):279–97.CrossRefPubMed

18.

Jochems EC, Mulder CL, Duivenvoorden HJ, van der Feltz-Cornelis CM, van Dam A. Measures of Motivation for Psychiatric Treatment Based on Self-Determination Theory: Psychometric Properties in Dutch Psychiatric Outpatients. Assessment [Internet]. 2014 Jan 2 [cited 17 Jan 2014];1–17. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24391079.

19.

Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale ( PANSS ) for schizophrenia. Schizophr Bull. 1987;13(2):261–72.CrossRefPubMed

20.

Weiden PJ, Miller AL. Which side effects really matter? Screening for common and distressing side effects of antipsychotic medications. J Psychiatr Pract. 2001;7:41–7.CrossRefPubMed

21.

Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R, et al. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry. 2009;70(4):1–46.PubMed

22.

Frey BS, Jegen R. Motivation crowding theory: a survey of empirical evidence, REVISED VERSION Juni 2000. J Econ Surv. 2001;15(49):589–611.CrossRef

Title: The effect of financial incentives on patients’ motivation for treatment: results of “Money for Medication,” a randomised controlled trial
Authors: Ernst L. Noordraven
André I. Wierdsma
Peter Blanken
Anthony F. T. Bloemendaal
Cornelis L. Mulder
Publication date: 01-12-2018
Publisher: BioMed Central
Published in: BMC Psychiatry / Issue 1/2018
Electronic ISSN: 1471-244X
DOI: https://doi.org/10.1186/s12888-018-1730-y

At a glance: The STEP trials

Springer Medicine

The effect of financial incentives on patients’ motivation for treatment: results of “Money for Medication,” a randomised controlled trial

Abstract

Background

Methods

Results

Conclusions

Trial registration

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2018

Extending research on Emotion Regulation Individual Therapy for Adolescents (ERITA) with nonsuicidal self-injury disorder: open pilot trial and mediation analysis of a novel online version

The burden of depressive disorders in South Asia, 1990–2016: findings from the global burden of disease study

Best practice framework for Patient and Public Involvement (PPI) in collaborative data analysis of qualitative mental health research: methodology development and refinement

Understanding the emotions of patients with inadequate response to antidepressant treatments: results of an international online survey in patients with major depressive disorder

The moderating roles of bedtime activities and anxiety/depression in the relationship between attention-deficit/hyperactivity disorder symptoms and sleep problems in children

An integrated approach to mental health and disaster preparedness: a cluster comparison with earthquake affected communities in Nepal